tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

PRNAF Stock Latest News

Promising Phase 2 Results and Technological Integration Justify Buy Rating for Alterity Therapeutics
RatingsPromising Phase 2 Results and Technological Integration Justify Buy Rating for Alterity Therapeutics
2h ago
ATHE
Alterity Therapeutics reports new data from ATH434 Phase 2 trial at AAN meeting
PremiumThe Fly
Alterity Therapeutics reports new data from ATH434 Phase 2 trial at AAN meeting
1d ago
ATHE
Alterity Therapeutics Unveils Promising Phase 2 Study Results for MSA Treatment
PremiumCompany Announcements
Alterity Therapeutics Unveils Promising Phase 2 Study Results for MSA Treatment
2d ago
Alterity Therapeutics Director Increases Stake Through Share Acquisition
PremiumCompany Announcements
Alterity Therapeutics Director Increases Stake Through Share Acquisition
3d ago
Regal Funds Management Becomes Substantial Holder in Alterity Therapeutics
PremiumCompany Announcements
Regal Funds Management Becomes Substantial Holder in Alterity Therapeutics
4d ago
BNY Mellon Reduces Stake in Alterity Therapeutics
PremiumCompany AnnouncementsBNY Mellon Reduces Stake in Alterity Therapeutics
4d ago
Alterity Therapeutics Completes A$38.79M Placement to Advance Neurodegenerative Disease Treatments
Premium
Company Announcements
Alterity Therapeutics Completes A$38.79M Placement to Advance Neurodegenerative Disease Treatments
5d ago
Alterity Therapeutics Issues Over 2.4 Billion Shares in Compliance with Corporations Act
Premium
Company Announcements
Alterity Therapeutics Issues Over 2.4 Billion Shares in Compliance with Corporations Act
5d ago
Alterity Therapeutics Announces Quotation of New Securities
PremiumCompany Announcements
Alterity Therapeutics Announces Quotation of New Securities
5d ago
Alterity Therapeutics to Present Promising ATH434 Phase 2 Results at Neurology Meeting
PremiumCompany Announcements
Alterity Therapeutics to Present Promising ATH434 Phase 2 Results at Neurology Meeting
9d ago
Alterity Therapeutics Secures Shareholder Approval for Key Resolutions
PremiumCompany Announcements
Alterity Therapeutics Secures Shareholder Approval for Key Resolutions
12d ago
Alterity Therapeutics completes last patient visit in ATH434-202 Phase 2 trial
PremiumThe Fly
Alterity Therapeutics completes last patient visit in ATH434-202 Phase 2 trial
15d ago
ATHE
Alterity Therapeutics to Quote New Securities on ASX
PremiumCompany AnnouncementsAlterity Therapeutics to Quote New Securities on ASX
29d ago
JPMorgan Chase Acquires Significant Stake in Alterity Therapeutics
Premium
Company Announcements
JPMorgan Chase Acquires Significant Stake in Alterity Therapeutics
29d ago
Alterity Therapeutics Reports Progress Amid Financial Losses
Premium
Company Announcements
Alterity Therapeutics Reports Progress Amid Financial Losses
1M ago
Buy Rating for Alterity Therapeutics: Strong Financial Position and Promising Clinical Results
PremiumRatings
Buy Rating for Alterity Therapeutics: Strong Financial Position and Promising Clinical Results
1M ago
ATHE
Alterity Therapeutics Announces Extraordinary General Meeting for Share Issuance Resolutions
PremiumCompany Announcements
Alterity Therapeutics Announces Extraordinary General Meeting for Share Issuance Resolutions
1M ago
Alterity Therapeutics Reports Increased Losses Amid Revenue Decline
PremiumCompany Announcements
Alterity Therapeutics Reports Increased Losses Amid Revenue Decline
1M ago
Alterity Therapeutics Announces Proposed Securities Issue to Bolster R&D Efforts
PremiumCompany Announcements
Alterity Therapeutics Announces Proposed Securities Issue to Bolster R&D Efforts
2M ago
Alterity Therapeutics Issues Over 1.1 Billion Shares
PremiumCompany AnnouncementsAlterity Therapeutics Issues Over 1.1 Billion Shares
2M ago
Alterity Therapeutics to List New Securities on ASX
Premium
Company Announcements
Alterity Therapeutics to List New Securities on ASX
2M ago
Alterity Therapeutics raises A$40M in placement
Premium
The Fly
Alterity Therapeutics raises A$40M in placement
2M ago
ATHE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >